Category

Daily Briefs

Daily Brief Utilities: Rubis SCA and more

By | Daily Briefs, Utilities Sector

In today’s briefing:

  • Rubis — Positive Q3 trading update


Rubis — Positive Q3 trading update

By Edison Investment Research

Rubis has provided an encouraging Q325 trading update that once again underscores the benefits of the company’s diversified business model and the defensive nature of its stock. Against the backdrop of volatile commodity prices and adverse forex moves the company reported a 3% y-o-y reduction in total revenues to €1,581m, supported by a 6% increase in volumes in its key Retail and Marketing division, which in turn saw broadly flat revenues and a 9% rebound in gross margin. Rubis reaffirmed its FY25 guidance, noting strong operational momentum. We have tweaked our estimates slightly, maintaining our valuation at €37.0/share.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Jardine Matheson Holdings, SK Square , LG Corp, Hamamatsu Photonics Kk, International Consolidated Air, BETA Technologies, Mitsuboshi Belting, R R Kabel, Tokai Holdings, Anest Iwata and more

By | Daily Briefs, Industrials

In today’s briefing:

  • On Jardine Matheson’s Latest Buyback
  • Square’s Level 2 Leverage Caps End Tomorrow — Fresh Near‑term Factor in the Square Vs Hynix Setup
  • LG Corp: NAV Analysis Suggests a 29% Upside, Likely to Catch Up to LG Chem
  • Hamamatsu Photonics (6965 JP): Capex Peaking, Profits to Rebound
  • International Airlines Group — Compounding a strong Q324 comparative
  • BETA Technologies (BETA US): Electric Takeoff to US & Global Indices
  • Mitsuboshi Belting (5192 JP): 1H FY03/26 flash update
  • RR Kabel Q2FY26: Strong Core, Aggressive Growth Path; Execution Key to Upside
  • Tokai Holdings (3167 JP): 1H FY03/26 flash update
  • Anest Iwata (6381 JP): 1H FY03/26 flash update


On Jardine Matheson’s Latest Buyback

By David Blennerhassett

  • On the 27th October, Jardine Matheson Holdings (JM SP) announced an Offer for 88.04%-held Mandarin Oriental International (MAND SP), after MAND concurrently announced the partial sale of OCB to Alibaba.  
  • MAND will pocket US$925mn from the sale. The privatisation will set Matheson back ~US$500mn. Alibaba is ostensibly funding MAND’s privatisation. And then some.  
  • Last week Matheson announced it will undertake a US$250mn buyback, which is expected to  complete in 2026.

Square’s Level 2 Leverage Caps End Tomorrow — Fresh Near‑term Factor in the Square Vs Hynix Setup

By Sanghyun Park

  • Square closed ₩290,000, missing all criteria; Level 2 removal effectively confirmed, with KRX disclosure expected ~8 p.m. Seoul, effective from tomorrow’s open.
  • Square vs Hynix hinges on retail chase structurally, but near‑term Square’s underperformance worsened by asymmetric leverage shackles.
  • Square’s Level 2 setup ends tomorrow; flows normalize, likely giving Square more juice vs Hynix. Key spot to watch from tomorrow’s open.

LG Corp: NAV Analysis Suggests a 29% Upside, Likely to Catch Up to LG Chem

By Douglas Kim

  • Our updated NAV valuation of LG Corp suggests implied market cap of 17.2 trillion won or target price of 111,605 won per share, representing 29.3% higher than current levels.
  • LG Corp’s investment stakes in LG Chem and LG Electronics are worth 15.7 trillion won representing 119% of LG Corp’s entire market cap.
  • Lower taxes on dividends could accelerate the capital allocation to companies with higher dividend yields/payouts such as LG Corp.

Hamamatsu Photonics (6965 JP): Capex Peaking, Profits to Rebound

By Scott Foster

  • Announced last Friday, FY Sep-25 sales and net profit were in line with guidance, but operating profit fell short. On Monday, the shares dropped 4.5%, wiping out a month’s gains.
  • Looking ahead, management expects three years of sales and profit growth as capex declines, depreciation and R&D level off, and the NKT Photonics acquisition approaches breakeven.
  • In this scenario, semiconductor, bio-medical, defense and quantum computing applications should drive 3-year sales growth of 24% and a 71% increase in net profit, bringing the P/E down to 20X.

International Airlines Group — Compounding a strong Q324 comparative

By Edison Investment Research

International Airlines Group’s (IAG’s) Q325 results show the company is executing effectively its strategy of delivering peer-leading profitability through a focus on customer experience and operational transformation, while returning substantial capital to shareholders. With a favourable demand outlook, likely lower cost pressures and a strong balance sheet, management intends to announce further returns with the publication of FY25 results in February 2026, and has optionality to undertake M&A.


BETA Technologies (BETA US): Electric Takeoff to US & Global Indices

By Dimitris Ioannidis

  • Electric aircraft company BETA Technologies (BETA US) went public on 4 November 2025 on NYSE and has a current market cap of over $7.5bn.
  • Inclusion in US indices is expected in December 2025 and March 2026, as the security meets US eligibility criteria before the lock-up expiry.
  • Earliest inclusion in Global indices is expected in February and June 2026, with potential delay due to free float and float cap constraints during the lock-up period.

Mitsuboshi Belting (5192 JP): 1H FY03/26 flash update

By Shared Research

  • Mitsuboshi’s revenue rose 0.9% YoY, with Belts segments offsetting lower Building & Construction Materials revenue.
  • The company plans to pay an annual dividend of JPY186 per share in FY03/26, unchanged from FY03/25.
  • Mitsuboshi announced a resolution to repurchase 350,000 shares, valued at JPY1.0bn, via market purchases on the Tokyo Stock Exchange.

RR Kabel Q2FY26: Strong Core, Aggressive Growth Path; Execution Key to Upside

By Sudarshan Bhandari

  • RR Kabel delivered a strong Q2FY26 with 19.5% YoY revenue growth and EBITDA doubling, driven by robust volume expansion in its high-margin Cables & Wires segment.
  • Solid core performance, backed by aggressive capex and margin expansion targets, positions RR Kabel as a key beneficiary of India’s accelerating infrastructure and industrial growth cycle.
  • RR Kabel remains structurally well-placed for growth, though long-term margin gains depend on timely capex execution and a successful turnaround of its FMEG business.

Tokai Holdings (3167 JP): 1H FY03/26 flash update

By Shared Research

  • FY03/26 sales were JPY114.5bn (+3.0% YoY), operating profit JPY6.2bn (+34.1% YoY), net income JPY3.6bn (+51.1% YoY).
  • Information and Communications sales to corporate clients rose 12.0% YoY, driven by carrier and cloud services growth.
  • Aqua services customer count increased by 16,000, surpassing 200,000, with sales JPY5.3bn (+9.9% YoY), operating profit JPY244mn (+82.9% YoY).

Anest Iwata (6381 JP): 1H FY03/26 flash update

By Shared Research

  • 1H FY03/26 results showed a decline in sales, operating profit, recurring profit, and net income YoY.
  • The company maintained its full-year earnings forecast, expecting higher costs and excluding foreign exchange gains/losses.
  • Capital expenditures planned at JPY3.5bn, with significant spending on digital upgrades and new prototype building.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Forum Engineering Inc, AAC Technologies Holdings, Xiaomi, Nationz Technologies Inc A, Taiwan Semiconductor (TSMC) – ADR, Navan, BILL Holdings , Upwork Inc, Nihon Denkei and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • [Japan M&A] KKR and Founder to Take Engineer Staffing Agency Forum Engineering (7088) Private
  • Quiddity Leaderboard HSTECH Dec25: AAC Tech up 9% Vs Peer; ~US$1.9bn One-Way; Announcement Soon
  • Forum Engineering (7088 JP): KKR’s Tender Offer at JPY1,710
  • Quiddity Leaderboard HSIII Dec25/Mar26: One Change for Dec25; New Expected ADD/DELs for Mar26
  • CSI All Share Semiconductor Index Rebalance Preview: Adds Starting to Outperform
  • Taiwan Tech Weekly: Nvidia Asking TSMC for More Capacity; Apple to Disintermediate Telcos?
  • Navan (NAVN US): Last IPO Addition for US Index in December 2025
  • 2024 High Conviction Update: BILL Holdings, Starboard Value and Elliott Move In
  • Primer: Upwork Inc (UPWK US) – Nov 2025
  • Nihon Denkei (9908 JP): 1H FY03/26 flash update


[Japan M&A] KKR and Founder to Take Engineer Staffing Agency Forum Engineering (7088) Private

By Travis Lundy

  • Today after the close, KKR announced a deal whereby they and founder OKUBO Izumi-san would take Forum Engineering Inc (7088 JP) private in an LBO. 
  • The process of this deal ticks most all of the “bad process” boxes but the price is pretty good.
  • 52% is locked in. Insiders and cross-holders appear to own another 15-18%. This looks like a done deal to me. Money comes 30 December.

Quiddity Leaderboard HSTECH Dec25: AAC Tech up 9% Vs Peer; ~US$1.9bn One-Way; Announcement Soon

By Janaghan Jeyakumar, CFA

  • The HSTECH Index tracks the performance of the top 30 technology companies listed in Hong Kong that have high business exposure to certain technology themes.
  • The official index changes and indicative weights for the December 2025 index rebal event will be announced publicly after the close on Friday 21st November 2025.
  • We continue to expect one index change for December 2025 and we estimate there to be capping flows of ~US$1.9bn one-way.

Forum Engineering (7088 JP): KKR’s Tender Offer at JPY1,710

By Arun George

  • Forum Engineering Inc (7088 JP) has recommended a tender offer from KKR & Co (KKR US) at JPY1,710, a 32.6% premium to the last close price.
  • The offer is arguably light due to a lack of an auction and is below the midpoint of the target IFA DCF valuation range. 
  • However, the offer is attractive compared to precedent transactions, peer multiples and represents an all-time high. The large number of cross-holders will help meet the required tendering rate.

Quiddity Leaderboard HSIII Dec25/Mar26: One Change for Dec25; New Expected ADD/DELs for Mar26

By Janaghan Jeyakumar, CFA

  • The Hang Seng Internet & IT (HSIII) index represents the top 30 stocks related to internet and information technology businesses listed in Hong Kong (HKEX).
  • We expect one index change in December 2025 translating to capping flows of US$530mn one-way.
  • We also expect seven index changes for the next semiannual index review which will take place in March 2026.

CSI All Share Semiconductor Index Rebalance Preview: Adds Starting to Outperform

By Brian Freitas

  • The review period for the December rebalance of the CSI All Share Semiconductor Index ended 31 October. The changes should be announced on 28 November and implemented on 12 December.
  • We forecast 3 adds and 6 deletes for the index with a one-way turnover of 1.4% and a round-trip trade of CNY 609m (US$85m).
  • The forecast adds have outperformed the forecast deletes over the last few weeks and stocks that have same-way flows from other index trackers could exhibit higher volatility near-term.

Taiwan Tech Weekly: Nvidia Asking TSMC for More Capacity; Apple to Disintermediate Telcos?

By Vincent Fernando, CFA

  • Nvidia Pushes TSMC for More Capacity as AI Chip Demand Surges
  • Apple Expands Its Satellite Ambitions for iPhones Beyond Just Emergencies — A Step Towards Disintermediating Telcos?
  • Nvidia’s International HQ in Taipei Deal Clears Final Hurdle — Boost for Taiwan 2026E-2027E

Navan (NAVN US): Last IPO Addition for US Index in December 2025

By Dimitris Ioannidis

  • Navan (NAVN US) went public on 30 October 2025 right before the December 2025 cut-off for a US IPO index addition with a current market cap of $4.5bn.
  • Inclusion in US indices is expected in December 2025, as the security meets US eligibility criteria before the lock-up expiry.
  • Inclusion in Global indices is expected in February 2026, prior to lock-up expiry, and September 2026 following lock-up expiry.

2024 High Conviction Update: BILL Holdings, Starboard Value and Elliott Move In

By Andrei Zakharov

  • BILL Holdings shares have bottomed out near $40 per share after Starboard Value and Elliott Management built large stakes in the American SMB back-office pioneer.
  • BILL Holding shares significantly underperformed in 2025 with shares down ~44% over the year versus a 21% gain on the Nasdaq.
  • I see further room for upside on potential launching new intelligent AI agents, partnerships with software providers, disciplined expense management and operating efficiency.

Primer: Upwork Inc (UPWK US) – Nov 2025

By αSK

  • Upwork is strategically pivoting to higher-value enterprise clients and leveraging Artificial Intelligence (AI) to drive growth, which is translating into improved profitability and strong cash flow generation.
  • The company operates in the rapidly expanding freelance platform market, benefiting from secular tailwinds such as the shift to remote work and the increasing adoption of flexible talent solutions by businesses globally.
  • While facing intense competition and macroeconomic sensitivity, Upwork’s established two-sided network of freelancers and clients provides a significant competitive advantage, though its ability to consistently translate this into high returns is still developing.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Nihon Denkei (9908 JP): 1H FY03/26 flash update

By Shared Research

  • Orders increased 7.6% YoY to JPY66.5bn, while order backlog rose 7.9% YoY to JPY47.5bn.
  • Operating profit declined 9.4% YoY to JPY1.2bn, with a gross profit of JPY7.4bn and GPM of 14.1%.
  • Nihon Denkei’s earnings forecast for FY03/26 includes sales of JPY124.0bn and net income of JPY3.0bn.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Hangzhou Kangji Medical Instrument Co., Ltd., Generation Bio , Olympus Corp, Artivion , Island Pharmaceuticals , Lantheus Holdings, MetaVia, Rani Therapeutics Holdings , SGX Rubber Future TSR20, Soligenix and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Kangji Medical (9997 HK): A Close Run Thing
  • Generation Bio’s Strategic Review: Potential 50% Upside Amid Restructuring and Cash Management Challenges
  • Olympus Corp (7733 JP): A Much-Awaited Turnaround On the Cards? One Quarter At a Time
  • Primer: Artivion (AORT US) – Nov 2025
  • Island Pharmaceuticals Ltd – Clinical Proof, Policy Pull
  • LNTH: Can AD Franchise Offset Pylarify Drag?
  • MTVA: 8-Week Data for 48 mg Cohort in Phase 1 Obesity Study Expected Before End of 2025
  • RANI: Third Quarter Results
  • Malaysia’s Glove Sector Gradually Recovers Amid Trade Shifts
  • SNGX: DMC Reports No Safety Signals for Ongoing Phase 3 Trial in CTCL Blinded Interim Efficacy Analysis in 1H26


Kangji Medical (9997 HK): A Close Run Thing

By David Blennerhassett

  • 6.95%. That’s the key number at yesterday’s Scheme Meeting for Hangzhou Kangji Medical Instrument Co., Ltd. (9997 HK).
  • That’s still below the 10% blocking stake. But closer than the bankers and the market was anticipating. 
  • Arguably, the terms were therefore bang on. Last day of trading is today, with payment on the 16th December.

Generation Bio’s Strategic Review: Potential 50% Upside Amid Restructuring and Cash Management Challenges

By Special Situation Investments

  • Generation Bio’s net cash is projected at $7.6/share, 50% above the current price, with limited ongoing cash burn.
  • The company completed restructuring, retaining seven employees, and is considering liquidation, reverse merger, or sale options.
  • Major shareholders include Atlas Venture Life Science (12.4%), T. Rowe Price (12.6%), Moderna (8.7%), Fidelity (6.9%), and BlackRock (5.1%).

Olympus Corp (7733 JP): A Much-Awaited Turnaround On the Cards? One Quarter At a Time

By Tina Banerjee

  • Olympus Corp (7733 JP) registered 20% QoQ rise in revenue to ¥247.8B in Q2FY26 while the adjusted operating profit witnessed 183% QoQ growth to ¥37.4B (margin expanded 870bps to 15.1%).
  • The company reiterated full-year forecasts for FY26. The company expects revenue to be ¥998B, flat YoY (+3% after FX adjustment).
  • Sequential improvement offers early green shoots. Moreover, decreasing “Elevate” program cost, product launches and venturing into endoluminal surgical robotics segment will slowly help propel growth in the near to midterm.

Primer: Artivion (AORT US) – Nov 2025

By αSK

  • Artivion is a niche leader in aortic repair, demonstrating strong revenue growth driven by its key product families: On-X mechanical heart valves, aortic stent grafts, and surgical sealants. The company is showing a clear trajectory towards sustained profitability, with recent quarters indicating positive net income and strong EBITDA margin expansion.
  • The company’s growth strategy is centered on product innovation and market expansion, highlighted by the promising clinical data and U.S. launch of the AMDS Hybrid Prosthesis for acute aortic dissections. This, along with other pipeline products like Arcevo, is expected to unlock significant market opportunities and drive future growth.
  • Despite its strong top-line performance, Artivion has a history of net losses and faces significant risks. These include intense competition from larger, better-resourced medical device companies, the inherent uncertainties of clinical trials and regulatory approvals, and potential operational disruptions such as the recently disclosed cybersecurity incident.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Island Pharmaceuticals Ltd – Clinical Proof, Policy Pull

By Research as a Service (RaaS)

  • Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
  • It is currently at clinical-stage and focused on two key antiviral assets – Galidesivir (a broad-spectrum RNA antiviral initially for Marburg) and ISLA-101 (a repurposed small-molecule drug initially for dengue).
  • We like ILA’s approach of focusing on existing drugs that can be repurposed, as considerable time, effort and investment has already been spent, while also increasing the probability of success for approval.

LNTH: Can AD Franchise Offset Pylarify Drag?

By Zacks Small Cap Research

  • Lantheus is a leader in radiopharmaceutical offerings in oncology & precision diagnostics.
  • It offers a portfolio of diagnostic & therapeutic products directly & via partnerships & licensing.
  • The primary revenue driver is Pylarify, a PET tracer for PSMA-expressing prostate cancer.

MTVA: 8-Week Data for 48 mg Cohort in Phase 1 Obesity Study Expected Before End of 2025

By Zacks Small Cap Research

  • On November 6, 2025, MetaVia Inc. (MTVA) announced financial results for the third quarter of 2025 and provided a business update.
  • We anticipate data from the 48 mg cohort from the Phase 1 trial of DA-1726, a dual GLP1/GCGR agonist, before the end of 2025.
  • This cohort was added to evaluate the non-titrated maximum tolerated dose of DA-1726.

RANI: Third Quarter Results

By Zacks Small Cap Research

  • Rani is a clinical-stage biotherapeutics company developing the ingestible robotic RaniPill (RP) that enables oral delivery of biologics & other large molecules.
  • Its pipeline features clinical assets RT-102 (teriparatide for osteoporosis) & RT-111 (ustekinumab for psoriasis).
  • Both programs have completed Ph1 trials characterizing safety tolerability & pharmacokinetics.

Malaysia’s Glove Sector Gradually Recovers Amid Trade Shifts

By Vinod Nedumudy

  • Glove demand rebounds as inventories normalize  
  • US tariffs boost Malaysian manufacturers’ market share  
  • Automation drives efficiency, supporting margin recovery

SNGX: DMC Reports No Safety Signals for Ongoing Phase 3 Trial in CTCL Blinded Interim Efficacy Analysis in 1H26

By Zacks Small Cap Research

  • On November 7, 2025, Soligenix, Inc. (SNGX) announced financial results for the third quarter of 2025 and provided a business update.
  • Recently, the Data Monitoring Committee (DMC) for the ongoing confirmatory Phase 3 clinical trial of HyBryte in the treatment of cutaneous T cell lymphoma (CTCL) concluded that there were no safety concerns and that HyBryte has an acceptable safety profile consistent with the safety data from all previous clinical studies.
  • We anticipate an update on enrollment from the company in the fourth quarter of 2025 and a pre-specified blinded interim efficacy analysis in the first half of 2026.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Shiseido Company, Shanghai Shenzhen CSI 300 Index, Yum China Holdings , Tata Motors, SHEIN, Treasury Wine Estates, Physicswallah Limited, Beijing Roborock Technology , SRS Holdings and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Shiseido (4911) | Progress on Reforms, but Growth Still Elusive
  • CSI 300 (SHSZ300) Tactical Outlook Ahead of December Rebalance
  • Quiddity Leaderboard HSCEI Dec25: Three Index Change Possible; ~US$264mn One-Way; Announcement Soon
  • SENSEX Index Rebalance Preview: Tata Motors OUT; Indigo IN; Grasim – Dark Horse
  • SHEIN Update: US$2 Bn Net, “Mid-Teens” Revenue Growth Targets Shared | New Challenges in France?
  • Treasury Wine Estates (TWE AU): Penfolds Owner at 11x P/E and 7% Dividend Yield
  • PhysicsWallah IPO: Driven by Passion to Educate; Sector Always in Controversy; No View on Valuation
  • Physicswallah IPO – RHP Updates and Thoughts on Valuation
  • Beijing Roborock (688169.SS): 3Q25 Review: Turn Around Delayed Further
  • SRS Holdings (8163 JP): 1H FY03/26 flash update


Shiseido (4911) | Progress on Reforms, but Growth Still Elusive

By Mark Chadwick

  • Shiseido’s Q3 revenue rose 4.6% YoY to ¥224bn, marking its first growth in three quarters, though full-year sales guidance was cut 3%.
  • Profitability remained pressured by tariffs and Drunk Elephant weakness; product margins fell 340bps YoY, but SG&A improvements limited overall margin decline to 80bps.
  • Management maintained core OP profit guidance and continued executing structural reforms, achieving ¥21bn cost savings YTD, with deeper efficiency cuts planned through 2026.

CSI 300 (SHSZ300) Tactical Outlook Ahead of December Rebalance

By Nico Rosti

  • As Brian Freitas recently outlined: the CSI 300 Index (SHSZ300) will undergo its semi-annual review by the end of November 2025, there could be profit-taking as we near that date.
  • In our previous insight we flagged potential downside tail risk. While the index hasn’t fallen since our warning, this doesn’t mean the risk has dissipated.
  • Our profit target model (the “go SHORT” model) is showing a rare pattern with very few rallies, severely limited upside (less than 1.5%) and an 80% reversal probability.Bearish.

Quiddity Leaderboard HSCEI Dec25: Three Index Change Possible; ~US$264mn One-Way; Announcement Soon

By Janaghan Jeyakumar, CFA

  • The HSCEI serves as a benchmark to reflect the overall performance of the top 50 “Mainland China” securities listed in Hong Kong.
  • The official index changes and indicative weights for the December 2025 index rebal event will be announced publicly after the close on Friday 21st November 2025.
  • We continue to expect three index changes for December 2025 and we estimate there to be capping flows of US$264mn one-way.

SENSEX Index Rebalance Preview: Tata Motors OUT; Indigo IN; Grasim – Dark Horse

By Brian Freitas


SHEIN Update: US$2 Bn Net, “Mid-Teens” Revenue Growth Targets Shared | New Challenges in France?

By Daniel Hellberg

  • Reportedly, SHEN recently shared FY25 targets of US$2 bn Net, “mid-teens” sales growth
  • SHEIN faces familiar issues in France, where the company has just opened a physical store
  • The release of new FY25 financial targets suggest SHEIN is progressing towards an IPO 

Treasury Wine Estates (TWE AU): Penfolds Owner at 11x P/E and 7% Dividend Yield

By Michael Fritzell

  • Treasury Wine Estates (TWE AU — US$3.0 billion) is one of the world’s largest wine producers globally. And it’s one of the very few large companies in Australia trading at a reasonable valuation multiple.

  • It started as the wine division of brewery giant Forster’s Group. From the 1990s onwards, Foster’s acquired vineyards and brands such as Penfolds, Lindeman’s and Beringer.

  • But throughout the 2000s, this wine division underperformed, draining cash from Foster’s highly profitable beer business. So in 2011, it was eventually spun off into a separately listed entity called Treasury Wine Estates (TWE).


PhysicsWallah IPO: Driven by Passion to Educate; Sector Always in Controversy; No View on Valuation

By Sreemant Dudhoria,CFA

  • Physicswallah Limited (2076103D IN) IPO opens today – 11 Nov 2025.The issue is a combination of fresh issue of INR 31 billion and offer for sale of INR 3.8 billion.
  • In this insight we discuss about the company, the industry, past controversies in the sector across major players.
  • We finally provide rationale why we do now know what valuation multiple to assign given the various factors.

Physicswallah IPO – RHP Updates and Thoughts on Valuation

By Sumeet Singh

  • Physicswallah Is looking to raise about US$434m in its upcoming India IPO.
  • Physicswallah Ltd (PWL) offers test preparation courses for competitive examinations, and other courses such as for upskilling, across 13 education categories, including JEE, NEET, and UPSC, among others.
  • We have looked at the company’s past performance in our earlier notes. In this note we talk about the RHP updates and provide our thoughts on valuations.

Beijing Roborock (688169.SS): 3Q25 Review: Turn Around Delayed Further

By Raj S, CA, CFA

  • Margins yet to recover – 3Q25 profitability remained under pressure from China promotions and early Vietnam cost drag.
  • Strong topline – revenue +61 % YoY, driven by broad-based global demand.
  • Recovery deferred – margin inflection likely only after efficiency gains and tariff easing.

SRS Holdings (8163 JP): 1H FY03/26 flash update

By Shared Research

  • Revenue increased to JPY37.2bn (+18.2% YoY), driven by new store openings and M&A activity in FY03/25.
  • Operating profit reached JPY1.6bn (+1.0% YoY), despite higher raw material and personnel costs impacting profitability.
  • The SRS group opened 13 restaurants, closed 18, and acquired six through M&A, ending with 781 restaurants.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Punjab National Bank, Bangkok Bank Public, Tejon Ranch , StepStone Group , Takara Leben, UOL Group, Anicom Holdings, Us Masters Residential Property Fund, Aruhi Corp, DWS Group GmbH & Co and more

By | Daily Briefs, Financials

In today’s briefing:

  • Four New Statistical Arbitrage Opportunities in Asia-Pac
  • Bangkok Bank (SET:BBL) Downgraded on Thailand-Cambodia Suspension of Peace Accord
  • TRC: TRC Intends to Outline Growth Drivers & Plans to Improve Shareholder Value at Upcoming Investor Event
  • Primer: StepStone Group (STEP US) – Nov 2025
  • Takara Leben (8897 JP): 1H FY03/26 flash update
  • Q&M, UOL & CLCT Directors Build Stakes
  • Anicom Holdings (8715 JP): 1H FY03/26 flash update
  • Primer: Us Masters Residential Property Fund (URF AU) – Nov 2025
  • Aruhi Corp (7198 JP): 1H FY03/26 flash update
  • Primer: DWS Group GmbH & Co (DWS GR) – Nov 2025


Four New Statistical Arbitrage Opportunities in Asia-Pac

By Gaudenz Schneider

  • Four stock pairs have triggered new mean-reversion trade signals, with price ratios deviating more than two standard deviations from their one-year averages.
  • Two of the opportunities involve companies in the same industry and two pairs involve companies in different industries within the same sector.
  • Essential for quantitative traders seeking mean-reversion opportunities, outlining opportunities and key risk considerations.

Bangkok Bank (SET:BBL) Downgraded on Thailand-Cambodia Suspension of Peace Accord

By Victor Galliano

  • We turn cautious on our sole positive Thai recommendation Bangkok Bank, downgrading it to neutral from buy, despite its very attractive value attributes
  • We believe that Thailand’s unilateral suspension of the peace accord in the Thailand-Cambodia conflict is likely to be negative for sentiment towards Thai equities, including banks, in the short term
  • Consequently, in the worsening investor climate, we do not expect Bangkok Bank shares to benefit from a re-rating over the short term

TRC: TRC Intends to Outline Growth Drivers & Plans to Improve Shareholder Value at Upcoming Investor Event

By Zacks Small Cap Research

  • TRC is hosting an Investor Day on Nov.
  • 14 2025, & has indicated that it intends to outline growth drivers and plans expected to improve shareholder value at the upcoming event.
  • The company has been criticized by key shareholders in recent months for not delivering value to shareholders.

Primer: StepStone Group (STEP US) – Nov 2025

By αSK

  • StepStone Group is a global private markets investment firm, providing customized investment solutions, advisory, and data services across private equity, real estate, infrastructure, and private debt.
  • The firm is well-positioned to benefit from the long-term secular growth in private markets, driven by increasing investor allocations seeking diversification and higher returns.
  • Key growth drivers include the expansion of its private wealth platform, which offers higher fee rates, and continued global expansion, although the company faces risks from market volatility and increasing regulatory scrutiny.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Takara Leben (8897 JP): 1H FY03/26 flash update

By Shared Research

  • Revenue decreased 34.5% YoY to JPY56.6bn, with operating profit at JPY12mn, a 99.7% YoY decline.
  • Real Estate Business saw a 39.7% YoY revenue drop and JPY1.8bn operating loss, with 313 units sold.
  • Energy Business revenue rose 10.5% YoY to JPY6.1bn, with operating profit up 102.1% YoY to JPY1.4bn.

Q&M, UOL & CLCT Directors Build Stakes

By Geoff Howie

  • Institutions were net sellers of Singapore stocks with a S$96 million outflow, led by REITs and Financial Services.
  • Nine companies conducted share buybacks totaling S$16.4 million, with United Overseas Bank buying back 240,000 shares.
  • Director transactions included 40 filings, with seven acquisitions by directors or CEOs and eight by substantial shareholders.

Anicom Holdings (8715 JP): 1H FY03/26 flash update

By Shared Research

  • Recurring revenue increased 10.6% YoY to JPY36.4bn, driven by underwriting, investment, and non-insurance business growth.
  • Recurring profit decreased 33.0% YoY to JPY2.1bn, impacted by costs related to AXA Direct insurance contract transfers.
  • Combined ratio based on earned premiums rose 3.7pp YoY to 97.2%, due to higher medical costs and policy transfer expenses.

Primer: Us Masters Residential Property Fund (URF AU) – Nov 2025

By αSK

  • URF is an Australian-listed property trust in a wind-down phase, focused on the orderly sale of its portfolio of residential properties in the New York metropolitan area to return capital to unitholders.
  • The Fund trades at a significant discount to its Net Asset Value (NAV), with a Price-to-Book ratio of approximately 0.62, offering potential value uplift as assets are liquidated. However, this is contingent on successful asset sales in a dynamic property market.
  • Financial performance has been weak, characterized by declining revenues, significant net losses, and negative operating cash flow in recent years, reflecting the challenges of its transition and wind-down strategy. The Fund has suspended dividend distributions.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Aruhi Corp (7198 JP): 1H FY03/26 flash update

By Shared Research

  • Operating revenue increased by 9.9% YoY to JPY11.8bn, driven by growth in recurring and asset-related revenue.
  • Operating expenses rose 13.3% YoY to JPY10.6bn, mainly due to higher finance and personnel costs.
  • Pre-tax profit decreased 12.2% YoY to JPY1.2bn, despite revenue growth, due to increased operating expenses.

Primer: DWS Group GmbH & Co (DWS GR) – Nov 2025

By αSK

  • DWS is a leading global asset manager with a strong brand, particularly in Germany and Europe, and benefits from its strategic relationship with Deutsche Bank, which provides a stable distribution channel.
  • The company is strategically focused on growing its higher-margin Alternatives and scalable Passive (Xtrackers ETFs) businesses, targeting double-digit compound annual growth rates in assets under management for both segments by 2025.
  • Significant headwinds include persistent fee compression across the industry, reputational damage from recent greenwashing allegations resulting in fines, and the challenge of navigating the broader shift from active to passive investment strategies.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Strategy, Xiaomi, Victory Giant Technology -A, Jardine Matheson Holdings, AUB Group Limited, Seres Group , SK Square , Huolinhe Opencut Coal Ind Corp Ltd., Forum Engineering Inc, LG Corp and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Index Consultation on DATCos Means MORE Selling Likely, and Another Index Questionable
  • Hang Seng Internet & IT Index (HSIII) Rebalance Preview: Methodology Change Leads to US$1.25bn Trade
  • CSI300 Index Rebalance Preview: 12 Changes a Side as Trade Nears US$10bn
  • On Jardine Matheson’s Latest Buyback
  • CVC Joins EQT In Pursuit Of AUB Group (AUB AU)
  • ECM Weekly (10 November 2025) – Seres, Pony, WeRide, Joyson, DIY, Maynilad, Northsand, Softcare
  • Square’s Level 2 Leverage Caps End Tomorrow — Fresh Near‑term Factor in the Square Vs Hynix Setup
  • CSI500/1000 Index Rebalance Preview: Adds Outperform Deletes Early On, Then Hit a Wall
  • [Japan M&A] KKR and Founder to Take Engineer Staffing Agency Forum Engineering (7088) Private
  • LG Corp: NAV Analysis Suggests a 29% Upside, Likely to Catch Up to LG Chem


Index Consultation on DATCos Means MORE Selling Likely, and Another Index Questionable

By Travis Lundy

  • In mid-September, global index provider M _ _ _ announced that they were conducting an index consultation on Digital Asset Treasury Cos. I wrote about it here.
  • My recommended short at the time is down 30%, despite announcing a large buyback program. Others have lost significant premium vs underlying digital assets. 
  • The same index provider expanded their list of affected names on 29 Oct. And a DIFFERENT Index provider this week added DATCOs to a US Advisory Panel Meeting Agenda Wednesday.

Hang Seng Internet & IT Index (HSIII) Rebalance Preview: Methodology Change Leads to US$1.25bn Trade

By Brian Freitas

  • Following the methodology update for the HSIII Index, there could be up to 5 constituent changes in December.
  • Estimated one-way turnover is 12.8% and that will result in a round-trip trade of HK$9.8bn (US$1.25bn).
  • Xiaomi (1810 HK) is the biggest beneficiary of the new methodology while there will be large funding outflows for a lot of the current index constituents.

CSI300 Index Rebalance Preview: 12 Changes a Side as Trade Nears US$10bn

By Brian Freitas

  • There could be 12 changes at the December rebalance with the Information Technology sector gaining 2 index spots and a smaller number of changes in the other sectors.
  • We estimate one-way turnover of 2.7% at the rebalance leading to a round-trip trade of CNY 69.8bn (US$9.8bn). There are 8 stocks with over 2x ADV to trade.
  • The forecast adds have outperformed the CSI 300 Index over the last 5 months while the forecast deletes have underperformed the index.

On Jardine Matheson’s Latest Buyback

By David Blennerhassett

  • On the 27th October, Jardine Matheson Holdings (JM SP) announced an Offer for 88.04%-held Mandarin Oriental International (MAND SP), after MAND concurrently announced the partial sale of OCB to Alibaba.  
  • MAND will pocket US$925mn from the sale. The privatisation will set Matheson back ~US$500mn. Alibaba is ostensibly funding MAND’s privatisation. And then some.  
  • Last week Matheson announced it will undertake a US$250mn buyback, which is expected to  complete in 2026.

CVC Joins EQT In Pursuit Of AUB Group (AUB AU)

By David Blennerhassett

  • On the 28th October 2025, AUB Group Limited (AUB AU), an insurance “matchmaker”, announced a NBIO, via a Scheme, from EQT at A$45/share, a ~40% premium to undisturbed.
  • The share price has consistently traded wide to terms, not just because of the transactions’ indicative nature; but EQT’s track record on progressing from indicative to firm is not optimum.
  • This morning AUB announced CVC was teaming up with EQT, at $45/share; and concurrently requested additional due diligence. This has been granted by AUB. 

ECM Weekly (10 November 2025) – Seres, Pony, WeRide, Joyson, DIY, Maynilad, Northsand, Softcare

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, the deal flow continues unabated, although a lot of listing in Hong Kong didn’t do to well last week.
  • On the placements front, there were a number of deals, with a few right at lockup expiry.

Square’s Level 2 Leverage Caps End Tomorrow — Fresh Near‑term Factor in the Square Vs Hynix Setup

By Sanghyun Park

  • Square closed ₩290,000, missing all criteria; Level 2 removal effectively confirmed, with KRX disclosure expected ~8 p.m. Seoul, effective from tomorrow’s open.
  • Square vs Hynix hinges on retail chase structurally, but near‑term Square’s underperformance worsened by asymmetric leverage shackles.
  • Square’s Level 2 setup ends tomorrow; flows normalize, likely giving Square more juice vs Hynix. Key spot to watch from tomorrow’s open.

CSI500/1000 Index Rebalance Preview: Adds Outperform Deletes Early On, Then Hit a Wall

By Brian Freitas

  • With the review period complete, we forecast 50 changes for the CSI Smallcap 500 Index and 100 changes for the CSI 1000 Index at the December rebalance.
  • We estimate a one-way turnover of 10.15% for the CSI Smallcap 500 Index and 10.22% for the CSI1000 Index. Gross round-trip trade across both indices is CNY 73.4bn (US$10.3bn).
  • The outright forecast adds have outperformed the outright forecast deletes over the last 6 months with most of the outperformance coming between June and August.

[Japan M&A] KKR and Founder to Take Engineer Staffing Agency Forum Engineering (7088) Private

By Travis Lundy

  • Today after the close, KKR announced a deal whereby they and founder OKUBO Izumi-san would take Forum Engineering Inc (7088 JP) private in an LBO. 
  • The process of this deal ticks most all of the “bad process” boxes but the price is pretty good.
  • 52% is locked in. Insiders and cross-holders appear to own another 15-18%. This looks like a done deal to me. Money comes 30 December.

LG Corp: NAV Analysis Suggests a 29% Upside, Likely to Catch Up to LG Chem

By Douglas Kim

  • Our updated NAV valuation of LG Corp suggests implied market cap of 17.2 trillion won or target price of 111,605 won per share, representing 29.3% higher than current levels.
  • LG Corp’s investment stakes in LG Chem and LG Electronics are worth 15.7 trillion won representing 119% of LG Corp’s entire market cap.
  • Lower taxes on dividends could accelerate the capital allocation to companies with higher dividend yields/payouts such as LG Corp.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Australia: Bluescope Steel, AUB Group Limited, Fenix Resources and more

By | Australia, Daily Briefs

In today’s briefing:

  • Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (10 Nov)
  • CVC Joins EQT In Pursuit Of AUB Group (AUB AU)
  • Fenix Resources (FEX AU): Pullback With Iron Ore Prices And Attractive Entry Point


Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (10 Nov)

By Gaudenz Schneider

  • Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities.
  • Highlights: Currently 14 pair trade opportunities across four markets and five sectors persist.
  • Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs.

CVC Joins EQT In Pursuit Of AUB Group (AUB AU)

By David Blennerhassett

  • On the 28th October 2025, AUB Group Limited (AUB AU), an insurance “matchmaker”, announced a NBIO, via a Scheme, from EQT at A$45/share, a ~40% premium to undisturbed.
  • The share price has consistently traded wide to terms, not just because of the transactions’ indicative nature; but EQT’s track record on progressing from indicative to firm is not optimum.
  • This morning AUB announced CVC was teaming up with EQT, at $45/share; and concurrently requested additional due diligence. This has been granted by AUB. 

Fenix Resources (FEX AU): Pullback With Iron Ore Prices And Attractive Entry Point

By Sameer Taneja


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Strategy, Echostar Corp A, Cognex Corp, Tyler Technologies, Blackline Inc, Bio-Rad Laboratories A, Avantor , Clean Harbors, Bausch + Lomb, Carmax Inc and more

By | Daily Briefs, United States

In today’s briefing:

  • Index Consultation on DATCos Means MORE Selling Likely, and Another Index Questionable
  • EchoStar Offloads Spectrum to SpaceX—Is This the End of Its Wireless Ambitions?
  • Cognex Corporation: Advancements and Penetration in the Logistics Sector & Key Growth Levers!
  • Tyler Technologies: Its Efforts Towards Cross-Sell & Upsell Initiatives to Drive Higher Growth & Revenue Potential From Current Accounts!
  • BlackLine Is A Takeover Target Again—And Investors Want It Gone!
  • Bio-Rad Laboratories Just Supercharged Its PCR Portfolio—Is This a Game-Changer in Oncology?
  • Avantor: Bioprocessing Innovation in Sterile Sampling & Other Key Growth Levers!
  • Clean Harbors Is Banking on 600N Base Oil – Can This Bet Up The Ante?
  • Bausch + Lomb Corporation’s Growth Surge: Can New Contact Lens Tech Grab A Larger Chunk Of The Market?
  • CarMax CEO Walks Out, Earnings Tank—Wall Street Sounds The Alarm!


Index Consultation on DATCos Means MORE Selling Likely, and Another Index Questionable

By Travis Lundy

  • In mid-September, global index provider M _ _ _ announced that they were conducting an index consultation on Digital Asset Treasury Cos. I wrote about it here.
  • My recommended short at the time is down 30%, despite announcing a large buyback program. Others have lost significant premium vs underlying digital assets. 
  • The same index provider expanded their list of affected names on 29 Oct. And a DIFFERENT Index provider this week added DATCOs to a US Advisory Panel Meeting Agenda Wednesday.

EchoStar Offloads Spectrum to SpaceX—Is This the End of Its Wireless Ambitions?

By Baptista Research

  • EchoStar’s recently amended agreement to sell its unpaired AWS-3 spectrum licenses to SpaceX for $2.6 billion in SpaceX stock represents a pivotal shift in its operational and strategic trajectory.
  • Building on a previous September deal where EchoStar committed to transferring AWS-4 and H-block licenses to SpaceX for up to $17 billion (half cash, half stock), this new AWS-3 transaction strengthens both firms’ long-term ambitions.
  • For EchoStar, this move not only unlocks immediate financial runway and positions it to operate more flexibly but also furthers its transformation from a spectrum-heavy, capital-intensive business into a leaner, investment-focused entity.

Cognex Corporation: Advancements and Penetration in the Logistics Sector & Key Growth Levers!

By Baptista Research

  • Cognex Corporation reported strong financial results for the third quarter of 2025, showcasing a solid strategic direction and improved operational efficiencies.
  • The company’s focus on AI technology for industrial machine vision is evident in its performance and the introduction of innovative products like the SLX, aimed at enhancing logistics applications.
  • Positive aspects from the results include achieving double-digit revenue growth and reaching the highest adjusted EBITDA margin since Q2 of 2023.

Tyler Technologies: Its Efforts Towards Cross-Sell & Upsell Initiatives to Drive Higher Growth & Revenue Potential From Current Accounts!

By Baptista Research

  • Tyler Technologies reported strong third-quarter 2025 results, with revenues growing by nearly 10% year-over-year.
  • This growth was driven by a 20% increase in SaaS revenue and an 11.5% rise in transaction revenue.
  • The company has maintained a steady pipeline of business, supported by stable RFP and demo activities, suggesting a resilient demand in the public sector for Tyler’s solutions.

BlackLine Is A Takeover Target Again—And Investors Want It Gone!

By Baptista Research

  • BlackLine, a leader in financial automation solutions, recently announced its Q1 2025 earnings results, highlighting both opportunities and challenges as the company navigates its ongoing journey towards growth and market expansion.
  • The company reported a total revenue increase of 6% year-over-year, reaching $167 million, with strong subscription and services revenue performance.
  • However, the financial results are a mix of positives and certain areas that might require attention.

Bio-Rad Laboratories Just Supercharged Its PCR Portfolio—Is This a Game-Changer in Oncology?

By Baptista Research

  • Bio-Rad Laboratories’ financial performance for the third quarter of 2025 was characterized by modest revenue growth, constrained by headwinds in various segments.
  • The company reported net sales of approximately $653 million, a slight increase from $650 million in the third quarter of 2024 on a reported basis but a 1.7% decrease on a currency-neutral basis.
  • This outcome was primarily influenced by challenges in the academic research and biotech funding sectors, which impacted the Life Science segment.

Avantor: Bioprocessing Innovation in Sterile Sampling & Other Key Growth Levers!

By Baptista Research

  • Avantor’s recent quarterly earnings report provides a mixed view of the company’s current performance and strategic outlook.
  • Avantor experienced a 5% decline in quarterly revenue year-over-year, with reported revenue of $1.62 billion.
  • The decline primarily affects the Laboratory Solutions and Bioscience Production segments.

Clean Harbors Is Banking on 600N Base Oil – Can This Bet Up The Ante?

By Baptista Research

  • Clean Harbors reported its third-quarter 2025 results, which showcased a mixture of strengths and challenges, leaving investors with a nuanced investment thesis.
  • The company’s performance was marked by a year-over-year growth in revenue and adjusted EBITDA, driven primarily by increased waste volumes and pricing gains across the network, although macroeconomic factors presented headwinds.
  • Positively, Clean Harbors achieved a consolidated adjusted EBITDA margin improvement of 100 basis points, reaching 20.7%, a sign of effective pricing and cost-saving strategies.

Bausch + Lomb Corporation’s Growth Surge: Can New Contact Lens Tech Grab A Larger Chunk Of The Market?

By Baptista Research

  • Bausch + Lomb recently held its third-quarter 2025 financial results presentation, highlighting several aspects of its performance and strategic focus.
  • The company demonstrated notable growth across its various segments, driven by innovative product offerings and rigorous execution.
  • Revenue for the quarter reached $1.281 billion, marking a 6% year-over-year increase.

CarMax CEO Walks Out, Earnings Tank—Wall Street Sounds The Alarm!

By Baptista Research

  • CarMax’s second quarter results for fiscal year 2026 reveal a mixed performance in a challenging market.
  • The company reported total sales of $6.6 billion, down 6% compared to the previous year, mainly due to lower volume.
  • Retail unit sales declined by 5.4%, while used unit comps fell by 6.3%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Samsung Fire & Marine Insurance, Orion Corp, SK Hynix and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Key Schedule for Korea’s Dividend Policy Momentum: This Thursday – Short‑term Target Group Screened
  • Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly 7 to 21 November 2025)
  • Curator’s Cut: Korea’s Memory Mania, Nintendo’s Next Play & Airline Takeoffs


Key Schedule for Korea’s Dividend Policy Momentum: This Thursday – Short‑term Target Group Screened

By Sanghyun Park

  • Dividend tax reform hits calendar: Assembly’s Strategy & Finance Committee starts hearings Nov 13; street buzzing as assembly headlines will push dividend theme.
  • Ruling party resists 25% payout threshold; cutting that low kills dividend incentive, while keeping 40% pushes corporates in 20–40% band to hike payouts.
  • From Thursday, dividend momentum likely drives locals into >4% yielders with >40% payout, so these names should be our near‑term targets.

Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly 7 to 21 November 2025)

By Douglas Kim

  • In this insight, we provide the top 10 stock picks and key catalysts in the Korean stock market for the next two weeks (7 to 21 November 2025).
  • Our top 10 picks in the next two weeks include KT&G, Samsung Electronics, Samsung Life Insurance, Orion Corp, Dentium, Hanmi Pharm, LG Chem (pref), Amorepacific Corp, Daewoong Pharm, and SK.  
  • Notable stocks with excellent share price performances in the past two weeks are as follows: Taihan Electric Wire (up 32.7%) Hanmi Pharm (up 29.5%), and SK Hynix (up 13.7%).

Curator’s Cut: Korea’s Memory Mania, Nintendo’s Next Play & Airline Takeoffs

By Pranav Rao

  • Welcome to Curator’s Cut — a fortnightly roundup of standout themes from the 1,500+ insights published on Smartkarma. 
  • In this cut, we revisit memory stocks’ stellar year, unpack results from the best pure-play gaming franchise, and spotlight airline stocks poised for lift-off.
  • Want to dig deeper? Comment or message with the themes you’d like to see highlighted next.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars